Wilfried Posch Selected Research

Wilfried Posch Research Topics

Disease

23	Infections 02/2024 - 01/2018
11	COVID-19 11/2023 - 01/2021
5	Mycoses (Diseases, Fungus) 12/2022 - 07/2015
3	Inflammation (Inflammations) 02/2024 - 09/2014
3	Convalescence 08/2023 - 01/2023
3	Candidiasis (Moniliasis) 02/2021 - 01/2017
2	Disease Progression 01/2023 - 01/2021
2	Virus Diseases (Viral Diseases) 10/2022 - 04/2010
2	Lung Injury 01/2022 - 01/2021
2	Invasive Candidiasis 02/2021 - 01/2017
2	Hemolytic-Uremic Syndrome 12/2020 - 01/2019
2	Neoplasms (Cancer) 07/2019 - 01/2019
2	Anemia 01/2017 - 09/2014
2	Chronic Disease (Chronic Diseases) 01/2017 - 09/2014
1	Human Influenza (Influenza) 02/2024
1	Chronic Renal Insufficiency 07/2023
1	Vasculitis (Vasculitides) 07/2023
1	Breakthrough Infections 01/2023
1	Non-Muscle Invasive Bladder Neoplasms 01/2023
1	Pulmonary Aspergillosis 12/2022
1	Sepsis (Septicemia) 07/2021
1	Candidemia 02/2021
1	Bacteremia 02/2021
1	Aspergillosis 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Coinfection 01/2019
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2019
1	Invasive Fungal Infections 01/2017
1	Primary Myelofibrosis (Myelosclerosis) 01/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 12/2016
1	HIV Infections (HIV Infection) 06/2015
1	Vaccinia 01/2013

Drug/Important Bio-Agent (IBA)

11	Complement System Proteins (Complement)IBA 01/2022 - 04/2010
6	N-(2-cyanoethylene)urea (BA 1)IBA 03/2023 - 01/2022
5	AntibodiesIBA 08/2023 - 01/2019
5	N-methyl-valyl-amiclenomycin (BA 2)IBA 03/2023 - 01/2022
5	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
3	AnaphylatoxinsIBA 02/2024 - 01/2021
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2021
3	VaccinesIBA 07/2023 - 10/2022
3	2019-nCoV Vaccine mRNA-1273IBA 07/2023 - 01/2022
3	BNT162 VaccineIBA 01/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2017
2	CytokinesIBA 02/2024 - 02/2021
2	Interferon Type IIBA 11/2023 - 10/2021
2	COVID-19 VaccinesIBA 08/2023 - 01/2023
2	Complement C3 (C3 Complement)IBA 03/2023 - 01/2023
2	tixagevimabIBA 01/2023 - 01/2022
2	regdanvimabIBA 01/2023 - 01/2022
2	Neutralizing AntibodiesIBA 01/2023 - 05/2022
2	sotrovimabIBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 01/2023 - 01/2022
2	AntigensIBA 01/2023 - 09/2019
2	cilgavimabIBA 01/2023 - 01/2022
2	Complement Receptors (Complement Receptor)IBA 01/2022 - 01/2020
2	Interleukin-17 (Interleukin 17)IBA 02/2021 - 01/2017
2	Shiga Toxins (Vero Toxin)IBA 12/2020 - 01/2019
2	IronIBA 01/2017 - 09/2014
2	Erythropoietin FDA Link 01/2017 - 09/2014
2	HepcidinsIBA 01/2017 - 09/2014
1	Chemokine CCL5IBA 02/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023
1	Immunoglobulins (Immunoglobulin)IBA 08/2023
1	mRNA VaccinesIBA 07/2023
1	SolutionsIBA 03/2023
1	Nasal SpraysIBA 03/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	EnzymesIBA 05/2022
1	galactomannanIBA 01/2022
1	Trinitrotoluene (TNT)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2021
1	PTX3 proteinIBA 02/2021
1	InterferonsIBA 02/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2021
1	Anaphylatoxin C5a ReceptorIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Janus Kinase 1IBA 01/2017
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Pattern Recognition ReceptorsIBA 12/2016
1	Amphotericin B (Amphotericin)FDA LinkGeneric 07/2015
1	HematinicsIBA 09/2014
1	Protein Kinase CIBA 01/2013

Therapy/Procedure

5	Therapeutics 11/2023 - 09/2014
1	Internal Fixators 01/2019
1	Hand Hygiene 01/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Immunotherapy 01/2017
1	Erythrocyte Transfusion 01/2017